Publications

Ibrutinib Versus Temsirolimus in Patients with Relapsed or Refractory Mantle-Cell Lymphoma: an International, Randomised, Open-Label, Phase Study

AuthID
P-00K-7CK

Author(s)

Dreyling, M

Jurczak, W

Jerkeman, M

Silva, RS

Rusconi, C

Trneny, M

Offner, F

Caballero, D

Joao, C

Witzens Harig, M

[+3]·

Bothos, J

Goldberg, JD

Enny, C

Traina, S

Balasubramanian, S

Bandyopadhyay, N

Sun, S

Vermeulen, J

Rizo, A

Rule, S

View all authors

Document Type

Article

Year published

2016

Published

in LANCET, ISSN: 0140-6736

Volume: 387, Issue: 10020, Pages: 770-778 (9)

Indexing

Wos^®

Scopus^®

Crossref^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/s0140-6736(15)00667-4

Scopus: 2-s2.0-84959074796

Wos: WOS:000370418000036

Source Identifiers

ISSN: 0140-6736

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

All authors

Show entries

Search:

Name Order	Name	Name Order	Name	Name Order	Name
1	Dreyling, M;	2	Jurczak, W;	3	Jerkeman, M;
4	Silva, RS;	5	Rusconi, C;	6	Trneny, M;
7	Offner, F;	8	Caballero, D;	9	Joao, C;
10	Witzens Harig, M;	11	Hess, G;	12	Bence Bruckler, I;
13	Cho, SG;	14	Bothos, J;	15	Goldberg, JD;
16	Enny, C;	17	Traina, S;	18	Balasubramanian, S;
19	Bandyopadhyay, N;	20	Sun, S;	21	Vermeulen, J;
22	Rizo, A;	23	Rule, S;

Showing 1 to 8 of 8 entries

Ibrutinib Versus Temsirolimus in Patients with Relapsed or Refractory Mantle-Cell Lymphoma: an International, Randomised, Open-Label, Phase Study

Useful Links

Get Help

Federated Authentication (Click on the image)

Ibrutinib Versus Temsirolimus in Patients with Relapsed or Refractory Mantle-Cell Lymphoma: an International, Randomised, Open-Label, Phase Study

Useful Links

Get Help